Article
Up to 40% of men with prostate cancer have a virus in their blood that, until now, has been linked to relatively rare cancers, new research from the University of Pittsburgh shows.
FDA reports Urgent Field Safety Notice on mini PCNL sheath
Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
Investigators identify potential dual targets in prostate cancer
Former MLB player Dave Winfield shares lessons from baseball, philanthropy
FDA greenlights phase 1/2 trial of gene editing therapy for primary hyperoxaluria 1
NCCN reaffirms Prolaris’ prognostic value in prostate cancer